Jurshak & Parma

Jurshak & Parma is a South Chicago insurance agency whose fiduciary work for Humboldt Chemical’s Xerxes plant placed it between the company, its employees, and insurance carriers. A 1963 report and later testimony connect the firm to efforts to present Xerxes as insurable despite mounting health claims, making its apparently routine insurance business a key part of V. I. Warshawski’s inquiry into occupational illness and corporate concealment.

Local Office and Political Setting

The firm’s storefront stood beside the ward office in a tidy brick two-flat on Avenue M in East Side. The building bore signs identifying Art Jurshak as alderman and Freddy Parma as ward committeeman; the insurance agency next door had given Art an early foothold in the community. The shared setting brought political and commercial life into close proximity, and the agency’s local presence was part of a broader network of business relationships around Art and his partner.

Warshawski’s account of that network includes companies for which Art or Parma obtained directorships and insurance business, including a trucking company, a steel firm, and a rail freight hauler. Contributions from those businesses flowed into political campaigns. The evidence presents these arrangements as part of Art’s established South Chicago influence, rather than as a detached insurance practice. In the dispute over a proposed SCRAP recycling center, Caroline Djiak also linked obstruction of a public hearing to the relationships between local officials and established political figures; that context places the agency within the neighborhood’s overlapping political and commercial structures, though it does not establish that the firm itself caused the hearing to be denied.

Xerxes Insurance and the 1963 Record

A document Warshawski found among Nancy Cleghorn’s papers was a photocopy of a 1963 letter to Mariners Rest Life Assurance Company. It stated that Jurshak & Parma had become fiduciaries for Humboldt Chemical’s Xerxes plant. Attached was an actuarial study describing Xerxes’s losses as comparable to those of other area companies and requesting the same rate consideration. At first, the paperwork seemed ordinary and unrelated to Nancy’s environmental work; its significance depended on understanding how the firm handled the plant’s insurance information.

Ron Kappelman read the document as suggesting that Xerxes might have been paying more than comparable businesses and that Jurshak was seeking lower rates from Mariners Rest. He could not confirm what Nancy had intended to show by keeping the paper. Warshawski, however, knew of Art’s wider insurance dealings and doubted that the arrangement was simply community-minded business. The gap between the report’s reassuring comparison of losses and the evidence of serious illness at Xerxes made the document newly consequential.

Workers’ Claims and Concealed Risk

The firm’s role mattered against the background of the workers’ compensation cases brought by Joey Pankowski and Steve Ferraro. Their lawyer first approached Humboldt Chemical, then filed suit when the company refused to negotiate. The company argued that smoking, drinking, and South Chicago’s polluted air made it impossible to prove that Xerxine had caused the men’s illnesses; it also argued that their exposure predated knowledge of the chemical’s toxicity. The claims failed, and an appellate lawyer saw no viable basis for an appeal. After the case, the lawyer received a threatening phone call warning generally about the dangers of using the appellate system, though it did not name the lawsuit.

Warshawski later connected the 1963 insurance report to the failed claims. She reasoned that favorable insurance terms could have depended on hiding Xerxes’s high illness and mortality rates. Her first account of the mechanism was a hypothesis: the company might have bought broader coverage than employees were told they had, with the fiduciary managing claims before they reached the insurer. The evidence subsequently supplied a more direct explanation of the firm’s function.

A Xerxes representative explained that Humboldt knew the workforce had too many health claims and was losing too much work time. The plant’s health-insurance costs rose sharply, Ajax Assurance dropped the company after a study found its claims too high, and Xerxes had to seek another carrier. Warshawski confronted him with the proposition that Jurshak had been engaged as fiduciary to alter the data and demonstrate that the company was insurable. He explained that it was intended to buy time while the company investigated the problem; the blood studies began during that period. This confirmation ties the agency’s handling of insurance information to a known pattern of worker illness, while also distinguishing the temporary insurance expedient from the later effort to identify the cause.

Significance in the Investigation

Jurshak & Parma’s importance lies in its position as an intermediary. The agency’s fiduciary role gave it access to information used in the company’s dealings with insurers, while workers’ access to compensation depended on proving that their illnesses were caused by workplace exposure. In Pankowski and Ferraro’s case, the company’s defenses focused on competing explanations and what was known about Xerxine at the time; the insurance records raised a different question about what the company disclosed when seeking coverage.

For Warshawski, a stale insurance letter initially appeared too mundane to explain Nancy’s death. Its meaning emerged only when she set it beside the failed compensation suit, the company’s difficulty obtaining insurance, and the later admission that Jurshak had helped alter the data used to establish insurability. The agency thus connects local patronage and commercial influence to the larger conflict over who controlled the evidence of risk—and who bore the costs when that evidence was obscured.